Peregrine and Stason Enter Into Agreement for Innovative Tumor Necrosis … – MarketWatch (press release)

Peregrine and Stason Enter Into Agreement for Innovative Tumor Necrosis … – MarketWatch (press release)

Peregrine and Stason Enter Into Agreement for Innovative Tumor Necrosis
MarketWatch (press release)
TUSTIN, CA and IRVINE, CA, May 03, 2010 (MARKETWIRE via COMTEX) — Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) , a clinical-stage biopharmaceutical
Peregrine, Stason enter cancer treatment agreementBioscience Technology



all 16 news articles »

0
Like
Save

Comments

Comments are disabled for this post.